pembrolizumab,mirvetuximab,durvalumab,ofranergene,Bevacizumab,Durvalumab,Olaparib,Carboplatin,Paclitaxel
merck,immunogen,astrazeneca,vbl therapeutics,roche
['pembro', 'ovarian', 'mirvetuximab', 'durva']
adc mirvetuximab soravtansine is a practice-changing treatment in the #ovariancancer space, with exciting concepts including vaccines, #durvalumab combination therapy, and #pembrolizumab taking centre stage! exciting times are ahead! #asco23 
Breast and Prostate Oncology fellow at The Kinghorn Cancer Centre. Podcaster, seeker of coffee, and new dad. Views my own. Fighting cancer one day at a time